In vitro and in vivo canine mononuclear cell production of tumor necrosis factor induced by muramyl peptides and lipopolysaccharide
- 1 September 1993
- journal article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 38 (1-2) , 45-56
- https://doi.org/10.1016/0165-2427(93)90112-h
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cytotoxic tumor necrosis factor activity produced by equine alveolar macrophages: preliminary characterizationVeterinary Immunology and Immunopathology, 1991
- Therapy for Osteosarcoma in Dogs With Intravenous Injection of Liposome-Encapsulated Muramyl TripeptideJNCI Journal of the National Cancer Institute, 1989
- Cytostatic product(s) released by activated macrophages, unrelated to interleukin 1, tumor necrosis factor α, and interferon-αβCellular Immunology, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Journal of Clinical Investigation, 1988
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- Molecular mechanisms in tumor-cell killing by activated macrophagesImmunology Today, 1983
- Lymphotoxin: Properties, role and mode of actionInternational Journal of Immunopharmacology, 1981
- Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.The Journal of Experimental Medicine, 1979
- Mechanism of Immunologically Specific Killing of Tumour Cells by MacrophagesNature, 1972